I
Intelligencia
Applying machine learning in drug development
About Intelligencia
Intelligencia AI is a health tech company that leverages artificial intelligence to revolutionize drug development in the pharmaceutical industry. By providing AI-driven insights, the company helps enhance clinical development, mitigate risks, and enable confident business decisions. Intelligencia AI serves many of the top global pharmaceutical companies, offering solutions built with comprehensive and precise data. Their services include real-time tracking of clinical programs, expert data curation, and quality control by biomedical professionals. The company's advanced algorithms provide accurate Probability of Technical and Regulatory Success (PTRS) assessments, validated retrospectively. Intelligencia AI operates in the health tech market, focusing on pharmaceutical clients who seek to improve their drug development processes. The business model revolves around offering AI-powered solutions and data analytics services, generating revenue through subscriptions and service fees from pharmaceutical companies.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- New York City, United States
- Sector
- Biotech & Life Sciences
- Power Law
- Colt$25–100M revenue
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Big Pi Ventures
MTIP
Synetro Group
ZS
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Intelligencia on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Intelligencia on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.